Mori M - Search Results

1

Possible liver damage by biosynthetic human insulin.

Shimizu H, Ohtani KI, Kudoh T, Tsuchiya T, Takahashi H, Sato N, Iriuchijima T, Mori M. Shimizu H, et al. Among authors: mori m. Diabetes Obes Metab. 1999 May;1(3):179-80. doi: 10.1046/j.1463-1326.1999.00029.x. Diabetes Obes Metab. 1999. PMID: 11220297 No abstract available.

2

Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients.

Shimizu H, Tsuchiya T, Sato N, Shimomura Y, Kobayashi I, Mori M. Shimizu H, et al. Among authors: mori m. Diabetes Care. 1998 Sep;21(9):1470-4. doi: 10.2337/diacare.21.9.1470. Diabetes Care. 1998. PMID: 9727893 Clinical Trial.

3

Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese Type 2 diabetic (T2DM) patients.

Shimizu H, Ohtani KI, Tsuchiya T, Sato N, Tanaka Y, Takahashi H, Uehara Y, Inukai T, Mori M. Shimizu H, et al. Among authors: mori m. Diabetes Nutr Metab. 2000 Apr;13(2):75-9. Diabetes Nutr Metab. 2000. PMID: 10898124

4

Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin.

Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M. Uehara Y, et al. Among authors: mori m. Diabetes. 1998 Jun;47(6):890-3. doi: 10.2337/diabetes.47.6.890. Diabetes. 1998. PMID: 9604864

5

Cyclo(His-Pro) concentration. Changes in brain striatum of hyperglycemic rat.

Mori M, Iriuchijima T, Yamada M. Mori M, et al. Diabetes. 1988 Aug;37(8):1120-2. doi: 10.2337/diab.37.8.1120. Diabetes. 1988. PMID: 2839388

6

Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients.

Shimizu H, Ohtani K, Tanaka Y, Sato N, Mori M, Shimomura Y. Shimizu H, et al. Among authors: mori m. Diabetes Res Clin Pract. 1995 Apr;28(1):35-40. doi: 10.1016/0168-8227(95)01056-j. Diabetes Res Clin Pract. 1995. PMID: 7587910 Clinical Trial.

7

Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients.

Sato N, Kashima K, Tanaka Y, Shimizu H, Mori M. Sato N, et al. Among authors: mori m. Diabetes. 1997 Jan;46(1):133-7. doi: 10.2337/diab.46.1.133. Diabetes. 1997. PMID: 8971093

8

Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients.

Sato N, Kashima K, Uehara Y, Ohtani K, Shimizu H, Mori M. Sato N, et al. Among authors: mori m. Diabetes Care. 1997 Jun;20(6):995-8. doi: 10.2337/diacare.20.6.995. Diabetes Care. 1997. PMID: 9167113 Clinical Trial.

9

Effect of eicosapentaenoic acid ethyl on urine albumin excretion in NIDDM.

Shimizu H, Sato N, Tanaka Y, Kashima K, Ohtani K, Mori M. Shimizu H, et al. Among authors: mori m. Diabetes Care. 1993 Oct;16(10):1406-8. doi: 10.2337/diacare.16.10.1406. Diabetes Care. 1993. PMID: 8269805 No abstract available.

10

Acarbose partially prevents the development of diabetes mellitus by multiple low-dose streptozotocin administration.

Negishi M, Shimizu H, Ohtani K, Mori M. Negishi M, et al. Among authors: mori m. Diabetes Res Clin Pract. 1996 Jun;33(1):15-9. doi: 10.1016/0168-8227(96)01254-5. Diabetes Res Clin Pract. 1996. PMID: 8877271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,953 results

Search Page

Filters